🇺🇸

US SEC Filing Intelligence

· daily

Contract Deobligations Alert — May 28, 2026

This digest of 15 government contracts, totaling $1.09 billion, is entirely civilian in nature, with zero defense-related awards. The dominant theme is IT modernization and professional services, led by Booz Allen Hamilton's $218.7M GSA engineering services award (potential $626.5M) and Venatorx Pharmaceuticals' $106.6M BARDA R&D contract. The highest-conviction signal is Booz Allen's cost-plus structure, which provides low-risk, stable revenue visibility. A key watch item is the high concentration of awards to small and privately-held firms (e.g., V3GATE, Four Points Technology, Zen Strategics), which limits direct public equity exposure and introduces execution risk on firm-fixed-price contracts.

15 total filings
· daily

Contract Option Exercises — May 28, 2026

This digest covers 15 civilian government contract option exercises totaling $1.09 billion, with zero defense-related awards. The dominant theme is civilian IT modernization and professional services, led by GSA FEDSIM ($218.7M to Booz Allen Hamilton) and BARDA health R&D ($106.6M to Venatorx Pharmaceuticals). The highest-conviction signal is Booz Allen's cost-plus contract, offering stable, low-risk revenue visibility through 2028. A key risk is the concentration of firm-fixed-price awards (e.g., Emergent LLC's $70.6M VA contract) that carry execution risk, and the absence of defense exposure limits tailwinds from NDAA priorities.

15 total filings
· daily

Federal Professional Services Contracts — May 28, 2026

This digest covers two civilian agency contracts totaling $290.2M in obligations, with zero defense-related awards. The dominant theme is stable, multi-year professional services demand from GSA and DHS, with Booz Allen Hamilton's $218.7M GSA FEDSIM award (potential $626.5M) representing the highest-conviction signal—a cost-plus structure that de-risks execution. Noblis's $71.5M DHS CWMD contract shows strong utilization but carries medium pricing risk due to time-and-materials terms. Key risk: both contracts are civilian, making them more vulnerable to discretionary budget cuts or CR-driven delays than defense programs. Watch for Booz Allen option exercises in FY2024-2028 and Noblis re-compete risk as its contract ends May 2026.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — May 28, 2026

This digest covers 7 civilian federal IT and cybersecurity contracts totaling $423.7 million in obligations, with zero defense-related awards. The dominant theme is civilian agency enterprise software and cloud services modernization, led by the Department of State and Department of Veterans Affairs. The highest-conviction signal is EMERGENT, LLC (MYTHICS, INC.) winning two large Oracle license awards worth a combined $122.7 million from the VA and State Department, signaling strong recurring revenue visibility. A key risk is the heavy concentration of awards to small and private firms—V3GATE, LLC, Four Points Technology, and Zen Strategics LLC—which limits direct public market exposure and introduces execution and revenue concentration risks.

7 total filings
· daily

All HHS Contracts — May 28, 2026

This single-record period captures a $106.6 million civilian R&D contract from BARDA (HHS) to Venatorx Pharmaceuticals Inc., a small biotech firm, signaling an urgent and well-funded push for health security experimental development. With zero defense-related awards, the sole signal is purely civilian and bullish, driven by a full-and-open competitive win that validates Venatorx’s platform. The contract’s cost-sharing structure introduces medium execution risk, as Venatorx must co-invest alongside the government, but the multi-year commitment through 2025 provides visible, non-dilutive revenue. The key watch item is the exercise of options, which will determine whether the total value grows from $106.6M to $146.9M, and the burn rate relative to the $36.7M currently outlayed.

1 total filings
· daily

General Federal Contracts — May 28, 2026

This digest covers 15 federal contracts totaling $1.09 billion, all awarded by civilian agencies (0% defense-related), signaling a robust non-DOD procurement environment. The dominant themes are IT services modernization (Booz Allen Hamilton, Peraton, Emergent, V3GATE) and health/biodefense R&D (Venatorx Pharmaceuticals), with the highest-conviction signal being Booz Allen Hamilton's $218.7M cost-plus-award-fee delivery order from GSA, which offers stable, lower-risk revenue and significant option upside to $626.5M. A key risk is the high concentration of awards to small, private, or nonprofit entities (e.g., Venatorx, Noblis, Mission for Essential Drugs), limiting direct public equity exposure, while the lack of defense contracts reduces sensitivity to NDAA-driven durability but increases vulnerability to civilian budget uncertainty under a Continuing Resolution.

15 total filings
· daily

All NASA Contracts — May 28, 2026

This digest covers a single $51.4M NASA contract awarded to AGILE DECISION SCIENCES, LLC, a subsidiary of the ARCTIC SLOPE REGIONAL CORPORATION, for administrative and IT support services at NASA Headquarters. The contract is entirely civilian, with zero defense-related exposure, and carries a bullish signal strength of 7/10. The highest-conviction signal is the stable, recurring revenue stream through 2026 under a cost-plus-fixed-fee structure, which limits margin upside but provides predictable cash flows. A key risk is the concentration of this revenue within the parent company's portfolio and the eventual expiration of 8(a) program eligibility, which could increase competitive pressure on future awards.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 28, 2026

The 18 filings reveal a bifurcated S&P 500 Technology landscape: enterprise software giants like Salesforce and Autodesk show robust revenue growth (13-18% YoY) and margin expansion, while quantum computing players (Pasqal, IBM) signal aggressive capital deployment. Key themes include heavy share repurchases at Salesforce ($27B in Q1) driving equity declines, Autodesk's $3.6B acquisition of MaintainX to expand into operations, and IBM's $10B quantum investment. Mixed signals emerge from insider activity (no major trades) and shareholder votes (notable opposition at Verizon, Esquire). The sector shows strong cash generation but rising debt levels, with Salesforce's debt surging to $39B. A catalyst calendar includes Pasqal's SPAC merger closing, Autodesk's acquisition close, and IBM's quantum milestones.

10 high priority 8 medium 18 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 28, 2026

The 15 filings from NASDAQ-100 constituents and related entities on May 28, 2026, reveal a mixed but cautiously optimistic market landscape. A key theme is aggressive capital management, exemplified by Sun Communities' new $1B buyback and Kennametal's debt refinancing, while M&A activity continues in financials and real estate. In healthcare, Immunic's mixed Phase 2 data for multiple sclerosis provides a nuanced outlook, balanced by Intuitive Surgical's positive leadership transition. Costco's strong Q3 results (11.6% YoY revenue growth) are tempered by adjusted comps of 6.6%, highlighting transitory tailwinds. Regulatory and corporate governance developments, including Verizon's shareholder meeting and NexMetals' unanimous approvals, show strong insider alignment. The overall sentiment reflects active portfolio restructuring and strategic positioning, with period comparisons showing notable revenue growth in consumer sectors but caution in clinical-stage biotech.

7 high priority 8 medium 15 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 28, 2026

The 50 filings from S&P 500 Financials and related sectors reveal a mixed landscape: while some companies like Salesforce and Burlington Stores show strong revenue and earnings growth, others like ZRCN and Investcorp AI Acquisition Corp report widening losses and cash depletion. Period-over-period comparisons highlight margin compression in industrials (Photronics, Hormel Foods) and retail (Build-A-Bear), offset by tariff refunds and cost-cutting. Insider activity is limited, but capital allocation trends show aggressive buybacks (Salesforce, Dollar Tree) and debt-funded M&A (GameStop). Forward-looking data points to catalysts in quantum computing (IBM), SPAC mergers (Cartesian Growth, NewHold), and regulatory milestones (ENDRA Life Sciences). Key risks include dilution from private placements (Hyperscale Data, Nature's Miracle) and shareholder dissent on governance (Yum China, COMPASS Pathways). Overall, the digest identifies 10 bullish signals, 9 risk flags, 10 opportunities, 5 sector themes, and 8 watch list items.

29 high priority 21 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 28, 2026

The 50 filings for the S&P 500 Consumer Staples sector reveal a sector bifurcating between scale-driven growth and margin pressure. Costco's 11.6% revenue surge and Hormel's 3% organic growth highlight the resilience of large-cap staples, but both show underlying margin compression from input costs and mix shifts. The most critical development is the activist-driven board refresh at lululemon, signaling potential strategic shifts. A clear theme is capital discipline, with buyback authorizations from El Pollo Loco ($40M) and Ambarella ($50M) alongside debt refinancing at Hexcel and Kinder Morgan, indicating a focus on shareholder returns and balance sheet optimization. However, the sector is not immune to risk, as seen in the debt restructuring at Nature's Miracle and the settlement at Celularity, which underscore financial strain in smaller players. The forward-looking data is sparse, but the few guidance items, like Hormel's lowered EPS outlook, suggest caution. Overall, the sector presents a 'growth with caution' narrative, favoring companies with strong pricing power and efficient capital allocation.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 28, 2026

The 50 filings from S&P 500 Industrials and related sectors reveal a bifurcated market: high-growth tech and aerospace companies (Dell, Autodesk, Howmet) are reporting record revenues and strong forward guidance, while consumer-facing and legacy industrial firms (Hormel, American Eagle, Photronics) show margin compression and mixed results. A significant theme is the aggressive capital allocation towards M&A and buybacks, with Autodesk's $3.6B acquisition of MaintainX and Hyatt's $1.0B buyback authorization standing out. However, this optimism is tempered by notable risk flags, including a Nasdaq deficiency notice for Lulu's Fashion Lounge, a default notice for Schmitt Industries, and a CEO resignation at the same firm, highlighting financial distress in smaller caps. Insider activity is sparse but includes a significant retention program at Karyopharm, suggesting a focus on talent retention. Overall, the portfolio shows strong revenue growth in tech-enabled industrials (Dell +88% YoY, Autodesk +18% YoY) but persistent margin pressures from product mix shifts and input costs, with several companies guiding cautiously for the remainder of 2026.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 28, 2026

Across five S&P 500 Energy-related filings, the dominant themes are consolidation & scale (Devon/Coterra merger), capital structure optimization (Kinder Morgan credit extension), and continued LNG expansion (Cheniere EPC award) juxtaposed with distressed micro-cap restructuring (Hallmark). Period comparisons show material outperformance at Devon (2025 oil volumes above top guidance and improved capital efficiency vs industry averages) and continued balance-sheet resilience at midstream (Kinder Morgan extending credit maturity to 2031). Forward catalysts cluster in 2H26–early-2027 (Devon merger vote/close processes, Cheniere FID and regulatory approvals). Insider and institutional position data are sparse but show stable institutional energy exposure (Challenger 13F holds Exxon $4.78M, Chevron $3.89M) and no alarmingly adverse insider sales in the large caps. Capital allocation is bifurcated: M&A and reinvestment (Devon merger synergies target $1B by 2027; Cheniere capex push) versus conservative liquidity management (Kinder Morgan keeps facility size unchanged but materially ups swingline availability). Net: prioritize Devon and Cheniere as growth/catalyst plays, treat Kinder Morgan as credit/defensive liquidity story, and avoid Hallmark absent structural revenue turnaround.

3 high priority 2 medium 5 total filings
· daily

US Material Events SEC 8-K Filings — May 28, 2026

The 50 filings reveal a mixed landscape with significant M&A activity (Caesars, Autodesk, Axalta/Akzo Nobel), capital market transactions (Sidus Space $100M offering, Polaryx $10M PIPE), and debt refinancings (Kinder Morgan, Hexcel). Period-over-period trends show margin compression in hospitality (Ashford Trust $60.7M Q1 loss) and energy (TXO Partners pro forma net loss of $74.3M), while tech-focused companies like MaintainX (>50% ARR growth) show strong momentum. Insider activity is limited but notable: multiple director resignations (Beeline, Hanmi, Schmitt Industries) and CFO departures (Cineverse, UGI). Forward-looking catalysts include the Caesars acquisition (Q3 2026), Autodesk/MaintainX close (FY2026), and Polaryx Phase 2 trial initiation. Capital allocation trends favor debt reduction (Red Robin, PBF Energy) and share buybacks (MAXIMUS). Key risks include Nasdaq non-compliance (ENDRA Life Sciences), heavy dilution (Hyperscale Data, Nature's Miracle), and regulatory delays (Etsy/eBay deal). Overall, the digest highlights a focus on balance sheet strengthening and strategic repositioning amid mixed sector performance.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 28, 2026

The 50 filings reveal a mixed landscape for Dow 30 and related companies. Revenue growth is robust in tech (Salesforce +13.3% YoY, Marvell +27.6% YoY, Ambarella +16.9% YoY), but margins are under pressure due to investment and cost inflation. Insider activity is limited, but notable insider selling at Marvell (CEO sold $1.2M) and insider buying at IBM (CEO bought $500K) signal divergent management conviction. Capital allocation shows aggressive buybacks at Salesforce ($27.4B in Q1) and new repurchase programs at El Pollo Loco ($40M) and Ambarella ($50M). M&A activity is significant, with Devon-Coterra merger targeting $1B synergies and Two Harbors acquisition facing shareholder resistance. Risk flags include Kohl's net loss, Lulu's Nasdaq deficiency, and Universal Corp's goodwill impairment. Key opportunities lie in IBM's quantum computing investment, Marvell's AI-driven growth, and Devon's merger synergies. Scheduled events include Two Harbors special meeting on June 11 and Yum China's share repurchase authority.

22 high priority 28 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 28, 2026

Today's filings reveal a market bifurcated between aggressive capital deployment and operational strain. A surge in SPAC activity, particularly in deep-tech sectors (quantum computing, nuclear energy, solid-state batteries), signals a renewed appetite for high-risk, long-duration assets, with Pasqal, NewCleo, and Factorial all progressing toward public listings. Conversely, consumer-facing companies like Burlington, Dollar Tree, and Build-A-Bear show a clear divergence: top-line growth is being maintained, but margin expansion is increasingly dependent on cost-cutting and one-time benefits (e.g., tariff refunds) rather than organic pricing power. A significant capital allocation theme has emerged, with Salesforce and Hyatt announcing massive share repurchase programs ($27.4B and $1.0B respectively), while distressed companies like Nature's Miracle and ENDRA Life Sciences resort to heavily dilutive financings to stave off collapse. The quantum computing sector received a major validation from IBM's $10B investment commitment, contrasting with the struggles of legacy tech firms like ZRCN Inc., which reported a widening net loss of $1.9B. Overall, the data suggests a 'haves and have-nots' market, where strong balance sheets are being used to aggressively reward shareholders, while weaker entities face existential liquidity challenges.

30 high priority 20 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 28, 2026

The 50 filings reveal a mixed picture for the S&P 500 Consumer Discretionary sector. Revenue growth is robust at several companies (Lowe's +10.3% YoY, American Eagle +10% YoY, Yum China stable), but margin pressures are evident from tariffs, inventory writedowns, and rising costs. Notable insider selling and guidance cuts at Hormel Foods (lowered EPS guidance) contrast with strong forward-looking data at Modine (40%+ EBITDA growth expected). Capital allocation is active: Lowe's completed large acquisitions, Salesforce repurchased $27.4B in stock, and several companies issued debt or equity. Risks include delisting threats (Lulu's Fashion Lounge, ENDRA Life Sciences) and shareholder dissent at annual meetings. The sector shows bifurcation between companies benefiting from data center/AI demand (Modine, Marvell) and those facing consumer headwinds (American Eagle brand decline). Overall, the data suggests selective opportunities in companies with strong guidance and insider confidence, while caution is warranted for those with deteriorating fundamentals.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 28, 2026

The 41 filings from the S&P 500 Healthcare stream reveal a sector bifurcated between capital-intensive growth plays and mature, cash-generating incumbents. Key themes include aggressive capital raising for development-stage assets (e.g., New Horizon Aircraft, ENDRA Life Sciences), proxy fights and activist engagement (Pacira BioSciences), and mixed operational performance where revenue growth is offset by margin compression and impairment charges (RCI Hospitality). Insider activity is sparse but notable, with a director resignation at Hanmi Financial and a CFO departure at Cineverse. Forward-looking data points to several high-impact catalysts, including a SPAC merger for Newcleo and a shareholder vote on a fund reorganization. The most critical development is the potential delisting risk for ENDRA Life Sciences, which overshadows its capital raise, while the Pacira proxy fight represents a high-conviction opportunity based on Glass Lewis's recommendation. Overall, the stream suggests a cautious but opportunistic stance, favoring companies with clear catalysts and strong governance over those with deteriorating fundamentals.

18 high priority 23 medium 41 total filings